{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:50:23Z","timestamp":1781333423396,"version":"3.54.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01837-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:58:39Z","timestamp":1774688319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Animal models of multiple sclerosis: applications and future directions in disease research"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9099-4145","authenticated-orcid":false,"given":"Sujitha","family":"R.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9701-8742","authenticated-orcid":false,"given":"Shajahan","family":"K.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7340-5618","authenticated-orcid":false,"given":"Yogalakshmi","family":"R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2080-3617","authenticated-orcid":false,"given":"Velan","family":"R. N.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9022-4583","authenticated-orcid":false,"given":"Khiren","family":"S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-2730","authenticated-orcid":false,"given":"Divya","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5511-0161","authenticated-orcid":false,"given":"Monisha","family":"A.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"9","key":"1837_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn.2887","volume":"14","author":"B Ajami","year":"2011","unstructured":"Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FMV (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14(9):1142\u20131149. https:\/\/doi.org\/10.1038\/nn.2887","journal-title":"Nat Neurosci"},{"key":"1837_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R (2015) Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol 6:492. https:\/\/doi.org\/10.3389\/fimmu.2015.00492","journal-title":"Front Immunol"},{"key":"1837_CR3","doi-asserted-by":"publisher","unstructured":"Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schr\u00f6der R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal Expansions of Cd8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by\u00a0micromanipulation and single cell polymerase chain reaction. J Exp Med 192(3):393\u2013404. https:\/\/doi.org\/10.1084\/jem.192.3.393","DOI":"10.1084\/jem.192.3.393"},{"issue":"2","key":"1837_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ni1430","volume":"8","author":"SL Bailey","year":"2007","unstructured":"Bailey SL, Schreiner B, McMahon EJ, Miller SD (2007) CNS myeloid DCs presenting endogenous myelin peptides preferentially polarize CD4\u2009+\u2009TH-17 cells in relapsing EAE. Nat Immunol 8(2):172\u2013180. https:\/\/doi.org\/10.1038\/ni1430","journal-title":"Nat Immunol"},{"issue":"3","key":"1837_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","volume":"26","author":"A Bar-Or","year":"2020","unstructured":"Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung H-P, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA (2020) Epstein\u2013Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies. Trends Mol Med 26(3):296\u2013310. https:\/\/doi.org\/10.1016\/j.molmed.2019.11.003","journal-title":"Trends Mol Med"},{"issue":"19","key":"1837_CR6","doi-asserted-by":"publisher","first-page":"11532","DOI":"10.3390\/ijms231911532","volume":"23","author":"D Birmpili","year":"2022","unstructured":"Birmpili D, Charmarke Askar I, Bigaut K, Bagnard D (2022) The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use. Int J Mol Sci 23(19):11532. https:\/\/doi.org\/10.3390\/ijms231911532","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1837_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jnr.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I (2018) Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis. J Neurosci Res 96(6):1021\u20131042. https:\/\/doi.org\/10.1002\/jnr.24224","journal-title":"J Neurosci Res"},{"issue":"4","key":"1837_CR8","doi-asserted-by":"publisher","first-page":"e00588","DOI":"10.1016\/j.neurot.2025.e00588","volume":"22","author":"G Bose","year":"2025","unstructured":"Bose G, Thebault SDX, Fadda G, Brooks JA, Freedman MS (2025) Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions. Neurotherapeutics 22(4):e00588. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00588","journal-title":"Neurotherapeutics"},{"key":"1837_CR9","doi-asserted-by":"publisher","unstructured":"Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen, J, Tolosa E (2009) Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132(12):3329\u20133341. https:\/\/doi.org\/10.1093\/brain\/awp289","DOI":"10.1093\/brain\/awp289"},{"issue":"1","key":"1837_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-016-0605-8","volume":"13","author":"SM Burm","year":"2016","unstructured":"Burm SM, Peferoen LAN, Zuiderwijk-Sick EA, Haanstra KG, Hart \u2018T, Van Der Valk BA, Amor P, Bauer S, J., Bajramovic JJ (2016) Expression of IL-1\u03b2 in rhesus EAE and MS lesions is mainly induced in the CNS itself. J Neuroinflamm 13(1):138. https:\/\/doi.org\/10.1186\/s12974-016-0605-8","journal-title":"J Neuroinflamm"},{"issue":"10","key":"1837_CR11","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4049\/jimmunol.0803418","volume":"182","author":"C Coisne","year":"2009","unstructured":"Coisne C, Mao W, Engelhardt B (2009a) Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis. J Immunol 182(10):5909\u20135913. https:\/\/doi.org\/10.4049\/jimmunol.0803418","journal-title":"J Immunol"},{"issue":"10","key":"1837_CR12","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4049\/jimmunol.0803418","volume":"182","author":"C Coisne","year":"2009","unstructured":"Coisne C, Mao W, Engelhardt B (2009b) Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis. J Immunol 182(10):5909\u20135913. https:\/\/doi.org\/10.4049\/jimmunol.0803418","journal-title":"J Immunol"},{"issue":"1","key":"1837_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","volume":"253","author":"AJ Coles","year":"2006","unstructured":"Coles AJ, Cox A, Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA (2006) The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy. J Neurol 253(1):98\u2013108. https:\/\/doi.org\/10.1007\/s00415-005-0934-5","journal-title":"J Neurol"},{"issue":"11","key":"1837_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0041-0101(01)00165-9","volume":"39","author":"RJ Collier","year":"2001","unstructured":"Collier RJ (2001) Understanding the mode of action of diphtheria toxin: A perspective on progress during the 20th century. Toxicon 39(11):1793\u20131803. https:\/\/doi.org\/10.1016\/S0041-0101(01)00165-9","journal-title":"Toxicon"},{"issue":"4","key":"1837_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"1837_CR16","doi-asserted-by":"publisher","first-page":"175628641985972","DOI":"10.1177\/1756286419859722","volume":"12","author":"R Cortese","year":"2019","unstructured":"Cortese R, Collorone S, Ciccarelli O, Toosy AT (2019) Advances in brain imaging in multiple sclerosis. Ther Adv Neurol Disord 12:1756286419859722. https:\/\/doi.org\/10.1177\/1756286419859722","journal-title":"Ther Adv Neurol Disord"},{"issue":"1\u20132","key":"1837_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(00)00409-4","volume":"112","author":"AH Cross","year":"2001","unstructured":"Cross AH, Trotter JL, Lyons JA (2001) B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112(1\u20132):1\u201314. https:\/\/doi.org\/10.1016\/S0165-5728(00)00409-4","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1837_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","volume":"1812","author":"AL Croxford","year":"2011","unstructured":"Croxford AL, Kurschus FC, Waisman A (2011) Mouse models for multiple sclerosis: Historical facts and future implications. Biochim et Biophys Acta (BBA) - Mol Basis Disease 1812(2):177\u2013183. https:\/\/doi.org\/10.1016\/j.bbadis.2010.06.010","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"3","key":"1837_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","volume":"43","author":"AL Croxford","year":"2015","unstructured":"Croxford AL, Lanzinger M, Hartmann FJ, Schreiner B, Mair F, Pelczar P, Clausen BE, Jung S, Greter M, Becher B (2015) The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2\u2009+\u2009Monocytes and Licenses Autoimmunity. Immunity 43(3):502\u2013514. https:\/\/doi.org\/10.1016\/j.immuni.2015.08.010","journal-title":"Immunity"},{"key":"1837_CR20","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.nbd.2023.106230","volume":"184","author":"S Dedoni","year":"2023","unstructured":"Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, Frau J, Cocco E, Fadda P (2023) An overall view of the most common experimental models for multiple sclerosis. Neurobiol Dis 184:106230. https:\/\/doi.org\/10.1016\/j.nbd.2023.106230","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1837_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","volume":"18","author":"A Denic","year":"2011","unstructured":"Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology 18(1):21\u201329. https:\/\/doi.org\/10.1016\/j.pathophys.2010.04.004","journal-title":"Pathophysiology"},{"key":"1837_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbi.2016.09.022","volume":"60","author":"KD DiSano","year":"2017","unstructured":"DiSano KD, Stohlman SA, Bergmann CC (2017) Activated GL7\u2009+\u2009B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. Brain Behav Immun 60:71\u201383. https:\/\/doi.org\/10.1016\/j.bbi.2016.09.022","journal-title":"Brain Behav Immun"},{"key":"1837_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.expneurol.2016.04.002","volume":"283","author":"ID Duncan","year":"2016","unstructured":"Duncan ID, Radcliff AB (2016) Inherited and acquired disorders of myelin: The underlying myelin pathology. Exp Neurol 283:452\u2013475. https:\/\/doi.org\/10.1016\/j.expneurol.2016.04.002","journal-title":"Exp Neurol"},{"issue":"4","key":"1837_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.174.4.1938","volume":"174","author":"S Ellmerich","year":"2005","unstructured":"Ellmerich S, Mycko M, Takacs K, Waldner H, Wahid FN, Boyton RJ, King RHM, Smith PA, Amor S, Herlihy AH, Hewitt RE, Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM (2005) High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model. J Immunol 174(4):1938\u20131946. https:\/\/doi.org\/10.4049\/jimmunol.174.4.1938","journal-title":"J Immunol"},{"issue":"2","key":"1837_CR25","doi-asserted-by":"publisher","first-page":"102609","DOI":"10.1016\/j.xcrm.2026.102609","volume":"7","author":"V Fleischer","year":"2026","unstructured":"Fleischer V, Schraad M, Gonzalez-Escamilla G, Schneider R, Brummer T, Steffen F, Protopapa M, Hanuscheck N, Salmen A, Meuth SG, Luessi F, Wiendl H, Klotz L, Gold R, Lukas C, Bittner S, Groppa S, Zipp F (2026) Choroid plexus enlargement associates with serum neurofilament and predicts relapse-free progression in multiple sclerosis. Cell Rep Med 7(2):102609. https:\/\/doi.org\/10.1016\/j.xcrm.2026.102609","journal-title":"Cell Rep Med"},{"issue":"2","key":"1837_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-5728(83)90017-6","volume":"4","author":"JO Fleming","year":"1983","unstructured":"Fleming JO, Ting JYP, Stohlman SA, Weiner LP (1983) Improvements in obtaining and characterizing mouse cerebrospinal fluid. J Neuroimmunol 4(2):129\u2013140. https:\/\/doi.org\/10.1016\/0165-5728(83)90017-6","journal-title":"J Neuroimmunol"},{"key":"1837_CR27","doi-asserted-by":"publisher","unstructured":"Furlan R, Cuomo C, Martino G (2009) Animal Models of Multiple Sclerosis. In: D. Gordon & N. J. Scolding (eds), Neural Cell Transplantation (Vol. 549, pp. 157\u2013173). Humana Press. https:\/\/doi.org\/10.1007\/978-1-60327-931-4_11","DOI":"10.1007\/978-1-60327-931-4_11"},{"issue":"3","key":"1837_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1352458516672017","volume":"23","author":"A Gafson","year":"2017","unstructured":"Gafson A, Craner MJ, Matthews PM (2017) Personalised medicine for multiple sclerosis care. Multiple Scler J 23(3):362\u2013369. https:\/\/doi.org\/10.1177\/1352458516672017","journal-title":"Multiple Scler J"},{"issue":"11","key":"1837_CR29","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.1073\/pnas.77.11.6376","volume":"77","author":"H Garoff","year":"1980","unstructured":"Garoff H, Frischauf AM, Simons K, Lehrach H, Delius H (1980) The capsid protein of Semliki Forest virus has clusters of basic amino acids and prolines in its amino-terminal region. Proc Natl Acad Sci 77(11):6376\u20136380. https:\/\/doi.org\/10.1073\/pnas.77.11.6376","journal-title":"Proc Natl Acad Sci"},{"key":"1837_CR30","doi-asserted-by":"publisher","first-page":"54616","DOI":"10.3791\/54616","volume":"117","author":"F Gilli","year":"2016","unstructured":"Gilli F, Royce DB, Pachner AR (2016) Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis. J Visualized Experiments 117:54616. https:\/\/doi.org\/10.3791\/54616","journal-title":"J Visualized Experiments"},{"issue":"8","key":"1837_CR31","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/awl075","volume":"129","author":"R Gold","year":"2006","unstructured":"Gold R (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(8):1953\u20131971. https:\/\/doi.org\/10.1093\/brain\/awl075","journal-title":"Brain"},{"issue":"4","key":"1837_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(93)90074-Z","volume":"72","author":"J Goverman","year":"1993","unstructured":"Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72(4):551\u2013560. https:\/\/doi.org\/10.1016\/0092-8674(93)90074-Z","journal-title":"Cell"},{"issue":"1","key":"1837_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25119","volume":"83","author":"AL Greenfield","year":"2018","unstructured":"Greenfield AL, Hauser SL (2018) B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol 83(1):13\u201326. https:\/\/doi.org\/10.1002\/ana.25119","journal-title":"Ann Neurol"},{"issue":"1","key":"1837_CR34","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1038\/ncomms6472","volume":"5","author":"S Gritsch","year":"2014","unstructured":"Gritsch S, Lu J, Thilemann S, W\u00f6rtge S, M\u00f6bius W, Bruttger J, Karram K, Ruhwedel T, Blanfeld M, Vardeh D, Waisman A, Nave K-A, Kuner R (2014) Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nat Commun 5(1):5472. https:\/\/doi.org\/10.1038\/ncomms6472","journal-title":"Nat Commun"},{"issue":"3","key":"1837_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2010.11.006","volume":"17","author":"\u2019T Hart","year":"2011","unstructured":"Hart \u2019T, Gran BA, B., Weissert R (2011) EAE: Imperfect but useful models of multiple sclerosis. Trends Mol Med 17(3):119\u2013125. https:\/\/doi.org\/10.1016\/j.molmed.2010.11.006","journal-title":"Trends Mol Med"},{"issue":"6","key":"1837_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1365-2990.2011.01168.x","volume":"37","author":"V Herder","year":"2011","unstructured":"Herder V, Hansmann F, Stangel M, Skripuletz T, Baumg\u00e4rtner W, Beineke A (2011) Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system: Scientific correspondence. Neuropathol Appl Neurobiol 37(6):676\u2013684. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01168.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1837_CR37","doi-asserted-by":"publisher","first-page":"1015035","DOI":"10.3389\/fphar.2022.1015035","volume":"13","author":"H Hong","year":"2022","unstructured":"Hong H, Lu X, Lu Q, Huang C, Cui Z (2022) Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders. Front Pharmacol 13:1015035. https:\/\/doi.org\/10.3389\/fphar.2022.1015035","journal-title":"Front Pharmacol"},{"issue":"3","key":"1837_CR38","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.4049\/jimmunol.166.3.1547","volume":"166","author":"LM Howard","year":"2001","unstructured":"Howard LM, Miller SD (2001) Autoimmune Intervention by CD154 Blockade Prevents T Cell Retention and Effector Function in the Target Organ. J Immunol 166(3):1547\u20131553. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1547","journal-title":"J Immunol"},{"issue":"8","key":"1837_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","volume":"22","author":"RW Jain","year":"2022","unstructured":"Jain RW, Yong VW (2022) B cells in central nervous system disease: Diversity, locations and pathophysiology. Nat Rev Immunol 22(8):513\u2013524. https:\/\/doi.org\/10.1038\/s41577-021-00652-6","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"1837_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/BF01191213","volume":"24","author":"ND Jeffery","year":"1995","unstructured":"Jeffery ND, Blakemore WF (1995) Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24(10):775\u2013781. https:\/\/doi.org\/10.1007\/BF01191213","journal-title":"J Neurocytol"},{"key":"1837_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2017.00024","volume":"11","author":"S J\u00e4kel","year":"2017","unstructured":"J\u00e4kel S, Dimou L (2017) Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation. Front Cell Neurosci 11:24. https:\/\/doi.org\/10.3389\/fncel.2017.00024","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1837_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11481-009-9178-y","volume":"5","author":"YS Kap","year":"2010","unstructured":"Kap YS, Laman JD, Hart \u2018T, B. A (2010) Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development. J Neuroimmune Pharmacol 5(2):220\u2013230. https:\/\/doi.org\/10.1007\/s11481-009-9178-y","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"1837_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: New insights into an old story. Acta Neuropathol 118(6):723\u2013736. https:\/\/doi.org\/10.1007\/s00401-009-0591-3","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1837_CR44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, the MSCOI Study Group, & the European Multiple Sclerosis Platform (2017) New insights into the burden and costs of multiple sclerosis in Europe. Multiple Scler J 23(8):1123\u20131136. https:\/\/doi.org\/10.1177\/1352458517694432","journal-title":"Multiple Scler J"},{"key":"1837_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nicl.2022.103194","volume":"103194","author":"H Kolb","year":"2022","unstructured":"Kolb H, Al-Louzi O, Beck ES, Sati P, Absinta M, Reich DS (2022) From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions. NeuroImage Clin 103194:36. https:\/\/doi.org\/10.1016\/j.nicl.2022.103194","journal-title":"NeuroImage Clin"},{"issue":"47","key":"1837_CR46","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","volume":"105","author":"T Korn","year":"2008","unstructured":"Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G, Vollmar P, Stritesky GL, Kaplan MH, Waisman A, Kuchroo VK, Oukka M (2008) IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. PNAS 105(47):18460\u201318465. https:\/\/doi.org\/10.1073\/pnas.0809850105","journal-title":"PNAS"},{"key":"1837_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.msard.2016.11.010","volume":"11","author":"P Kulkarni","year":"2017","unstructured":"Kulkarni P, Yellanki S, Medishetti R, Sriram D, Saxena U, Yogeeswari P (2017) Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis. Multiple Scler Relat Disorders 11:32\u201339. https:\/\/doi.org\/10.1016\/j.msard.2016.11.010","journal-title":"Multiple Scler Relat Disorders"},{"key":"1837_CR48","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.expneurol.2013.02.014","volume":"247","author":"NJ Kuypers","year":"2013","unstructured":"Kuypers NJ, James KT, Enzmann GU, Magnuson DSK, Whittemore SR (2013) Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Exp Neurol 247:615\u2013622. https:\/\/doi.org\/10.1016\/j.expneurol.2013.02.014","journal-title":"Exp Neurol"},{"key":"1837_CR49","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2019","unstructured":"Lassmann H (2019) Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis. Front Immunol 9:3116. https:\/\/doi.org\/10.3389\/fimmu.2018.03116","journal-title":"Front Immunol"},{"issue":"2","key":"1837_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: Experimental models and reality. Acta Neuropathol 133(2):223\u2013244. https:\/\/doi.org\/10.1007\/s00401-016-1631-4","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1837_CR51","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.4049\/jimmunol.1300822","volume":"191","author":"T Leuenberger","year":"2013","unstructured":"Leuenberger T, Paterka M, Reuter E, Herz J, Niesner RA, Radbruch H, Bopp T, Zipp F, Siffrin V (2013) The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35\u201355\u2013induced experimental autoimmune encephalomyelitis. J Immunol 191(10):4960\u20134968. https:\/\/doi.org\/10.4049\/jimmunol.1300822","journal-title":"J Immunol"},{"issue":"4","key":"1837_CR52","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00705-021-04968-5","volume":"166","author":"JE Libbey","year":"2021","unstructured":"Libbey JE, Fujinami RS (2021) Viral mouse models used to study multiple sclerosis: Past and present. Arch Virol 166(4):1015\u20131033. https:\/\/doi.org\/10.1007\/s00705-021-04968-5","journal-title":"Arch Virol"},{"key":"1837_CR53","doi-asserted-by":"publisher","first-page":"797298","DOI":"10.3389\/fphar.2021.797298","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Xiang H, Huang C, Lu J (2021a) Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models. Front Pharmacol 12:797298. https:\/\/doi.org\/10.3389\/fphar.2021.797298","journal-title":"Front Pharmacol"},{"key":"1837_CR54","doi-asserted-by":"publisher","first-page":"797298","DOI":"10.3389\/fphar.2021.797298","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Xiang H, Huang C, Lu J (2021b) Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models. Front Pharmacol 12:797298. https:\/\/doi.org\/10.3389\/fphar.2021.797298","journal-title":"Front Pharmacol"},{"issue":"1","key":"1837_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2040-7378-1-5","volume":"1","author":"RA Linker","year":"2009","unstructured":"Linker RA, Lee D-H (2009) Models of autoimmune demyelination in the central nervous system: On the way to translational medicine. Experimental Translational Stroke Med 1(1):5. https:\/\/doi.org\/10.1186\/2040-7378-1-5","journal-title":"Experimental Translational Stroke Med"},{"issue":"3","key":"1837_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nn.2491","volume":"13","author":"L Liu","year":"2010","unstructured":"Liu L, Belkadi A, Darnall L, Hu T, Drescher C, Cotleur AC, Padovani-Claudio D, He T, Choi K, Lane TE, Miller RH, Ransohoff RM (2010) CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: Relevance to multiple sclerosis. Nat Neurosci 13(3):319\u2013326. https:\/\/doi.org\/10.1038\/nn.2491","journal-title":"Nat Neurosci"},{"issue":"3","key":"1837_CR57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Polman CH (2014) Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 83(3):278\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"issue":"9","key":"1837_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan M, Nevin ZS, Shick HE, Garrison E, Clarkson-Paredes C, Karl M, Clayton BLL, Factor DC, Allan KC, Barbar L, Jain T, Douvaras P, Fossati V, Miller RH, Tesar PJ (2018) Induction of myelinating oligodendrocytes in human cortical spheroids. Nat Methods 15(9):700\u2013706. https:\/\/doi.org\/10.1038\/s41592-018-0081-4","journal-title":"Nat Methods"},{"issue":"21","key":"1837_CR59","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.3390\/ijms262110771","volume":"26","author":"F Mailaender","year":"2025","unstructured":"Mailaender F, Vasilenko N, Tieck MP, Schembecker S, Kowarik MC (2025) The Elusive B Cell Antigen in Multiple Sclerosis: Time to Rethink CNS B Cell Functions. Int J Mol Sci 26(21):10771. https:\/\/doi.org\/10.3390\/ijms262110771","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1837_CR60","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/biomedicines12102354","volume":"12","author":"B Maktabi","year":"2024","unstructured":"Maktabi B, Collins A, Safee R, Bouyer J, Wisner AS, Williams FE, Schiefer IT (2024) Zebrafish as a Model for Multiple Sclerosis. Biomedicines 12(10):2354. https:\/\/doi.org\/10.3390\/biomedicines12102354","journal-title":"Biomedicines"},{"issue":"2","key":"1837_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbadis.2010.07.006","volume":"1812","author":"LT Mars","year":"2011","unstructured":"Mars LT, Saikali P, Liblau RS, Arbour N (2011) Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim et Biophys Acta (BBA) - Mol Basis Disease 1812(2):151\u2013161. https:\/\/doi.org\/10.1016\/j.bbadis.2010.07.006","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"4","key":"1837_CR62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ana.410370415","volume":"37","author":"L Massacesi","year":"1995","unstructured":"Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL (1995) Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann Neurol 37(4):519\u2013530. https:\/\/doi.org\/10.1002\/ana.410370415","journal-title":"Ann Neurol"},{"issue":"1","key":"1837_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/npp.2008.145","volume":"34","author":"JE Merrill","year":"2009","unstructured":"Merrill JE (2009) In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination. Neuropsychopharmacology 34(1):55\u201373. https:\/\/doi.org\/10.1038\/npp.2008.145","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1837_CR64","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","volume":"92","author":"E Mix","year":"2010","unstructured":"Mix E, Meyer-Rienecker H, Hartung H-P, Zettl UK (2010) Animal models of multiple sclerosis\u2014Potentials and limitations. Prog Neurobiol 92(3):386\u2013404. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.06.005","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1837_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 Cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7(1):145\u2013173. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.001045","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"1837_CR66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1084\/jem.20020390","volume":"196","author":"M Munder","year":"2002","unstructured":"Munder M, Bettelli E, Monney L, Slavik JM, Nicholson LB, Kuchroo VK (2002) Reduced Self-Reactivity of an Autoreactive T Cell After Activation with Cross-reactive Non\u2013Self-Ligand. J Exp Med 196(9):1151\u20131162. https:\/\/doi.org\/10.1084\/jem.20020390","journal-title":"J Exp Med"},{"issue":"7","key":"1837_CR67","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI17935","volume":"112","author":"N Najafian","year":"2003","unstructured":"Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, Yuan X, Clarkson MR, Sayegh MH, Khoury SJ (2003) Regulatory functions of CD8+CD28\u2013 T cells in an autoimmune disease model. J Clin Invest 112(7):1037\u20131048. https:\/\/doi.org\/10.1172\/JCI17935","journal-title":"J Clin Invest"},{"issue":"2","key":"1837_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ajhg.2017.06.012","volume":"101","author":"KE Ormond","year":"2017","unstructured":"Ormond KE, Mortlock DP, Scholes DT, Bombard Y, Brody LC, Faucett WA, Garrison NA, Hercher L, Isasi R, Middleton A, Musunuru K, Shriner D, Virani A, Young CE (2017) Human Germline Genome Editing. Am J Hum Genet 101(2):167\u2013176. https:\/\/doi.org\/10.1016\/j.ajhg.2017.06.012","journal-title":"Am J Hum Genet"},{"issue":"23","key":"1837_CR69","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1080\/09638288.2020.1741698","volume":"43","author":"L-S Parker","year":"2021","unstructured":"Parker L-S, Topcu G, De Boos D, Das Nair R (2021) The notion of invisibility in people\u2019s experiences of the symptoms of multiple sclerosis: A systematic meta-synthesis. Disabil Rehabil 43(23):3276\u20133290. https:\/\/doi.org\/10.1080\/09638288.2020.1741698","journal-title":"Disabil Rehabil"},{"issue":"1","key":"1837_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.111.1.119","volume":"111","author":"PY Paterson","year":"1960","unstructured":"Paterson PY, ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS (1960) TRANSFER OF ALLERGIC. J Exp Med 111(1):119\u2013136. https:\/\/doi.org\/10.1084\/jem.111.1.119","journal-title":"J Exp Med"},{"issue":"3","key":"1837_CR71","doi-asserted-by":"publisher","first-page":"a029058","DOI":"10.1101\/cshperspect.a029058","volume":"9","author":"A Paul","year":"2019","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in Multiple Sclerosis. Cold Spring Harbor Perspect Med 9(3):a029058. https:\/\/doi.org\/10.1101\/cshperspect.a029058","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"2","key":"1837_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jneumeth.2007.03.013","volume":"163","author":"M Peiris","year":"2007","unstructured":"Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ (2007) A model of experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice for the characterisation of intervention therapies. J Neurosci Methods 163(2):245\u2013254. https:\/\/doi.org\/10.1016\/j.jneumeth.2007.03.013","journal-title":"J Neurosci Methods"},{"issue":"6","key":"1837_CR73","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.coi.2011.08.007","volume":"23","author":"A Peters","year":"2011","unstructured":"Peters A, Lee Y, Kuchroo VK (2011) The many faces of Th17 cells. Curr Opin Immunol 23(6):702\u2013706. https:\/\/doi.org\/10.1016\/j.coi.2011.08.007","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1837_CR74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/glia.22755","volume":"63","author":"MA Preston","year":"2015","unstructured":"Preston MA, Macklin WB (2015) Zebrafish as a model to investigate CNS myelination. Glia 63(2):177\u2013193. https:\/\/doi.org\/10.1002\/glia.22755","journal-title":"Glia"},{"key":"1837_CR75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini C, De Rosa V, Pucino V, Formisano L, Matarese G (2015) Animal models of Multiple Sclerosis. Eur J Pharmacol 759:182\u2013191. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.042","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1837_CR76","doi-asserted-by":"publisher","first-page":"9.7.1","DOI":"10.1002\/0471142301.ns0907s14","volume":"14","author":"MK Racke","year":"2001","unstructured":"Racke MK (2001) Experimental Autoimmune Encephalomyelitis (EAE). Curr Protoc Neurosci 14(1):9.7.1\u20139.7.11. https:\/\/doi.org\/10.1002\/0471142301.ns0907s14","journal-title":"Curr Protoc Neurosci"},{"issue":"1","key":"1837_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.stem.2011.11.019","volume":"10","author":"JM Ruckh","year":"2012","unstructured":"Ruckh JM, Zhao J-W, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJM (2012) Rejuvenation of Regeneration in the Aging Central Nervous System. Cell Stem Cell 10(1):96\u2013103. https:\/\/doi.org\/10.1016\/j.stem.2011.11.019","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1837_CR78","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10571-015-0279-2","volume":"36","author":"NA Salem","year":"2016","unstructured":"Salem NA, Assaf N, Ismail MF, Khadrawy YA, Samy M (2016) Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect. Cell Mol Neurobiol 36(6):943\u2013954. https:\/\/doi.org\/10.1007\/s10571-015-0279-2","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1837_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/bph.12938","volume":"172","author":"A Slowik","year":"2015","unstructured":"Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M (2015) The sphingosine 1-phosphate receptor agonist FTY 720 is neuroprotective after cuprizone\u2010induced CNS demyelination. Br J Pharmacol 172(1):80\u201392. https:\/\/doi.org\/10.1111\/bph.12938","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1837_CR80","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1191\/1352458505ms1210oa","volume":"11","author":"DR Smith","year":"2005","unstructured":"Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H (2005) A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta. Mult Scler 11(5):573\u2013582. https:\/\/doi.org\/10.1191\/1352458505ms1210oa","journal-title":"Mult Scler"},{"issue":"2","key":"1837_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0042-6822(84)90227-7","volume":"137","author":"O Sorensen","year":"1984","unstructured":"Sorensen O, Coulter-Mackie MB, Puchalski S, Dales S (1984) In vivo and in vitro models of demyelinating disease IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases. Virology 137(2):347\u2013357. https:\/\/doi.org\/10.1016\/0042-6822(84)90227-7","journal-title":"Virology"},{"issue":"1","key":"1837_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4049\/jimmunol.163.1.40","volume":"163","author":"A Stefferl","year":"1999","unstructured":"Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C (1999) Myelin Oligodendrocyte Glycoprotein Induces Experimental Autoimmune Encephalomyelitis in the Resistant Brown Norway Rat: Disease Susceptibility Is Determined by MHC and MHC-Linked Effects on the B Cell Response. J Immunol 163(1):40\u201349. https:\/\/doi.org\/10.4049\/jimmunol.163.1.40","journal-title":"J Immunol"},{"issue":"1","key":"1837_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/PL00000576","volume":"53","author":"D Teitelbaum","year":"1997","unstructured":"Teitelbaum D, Arnon R, Sela M (1997) Copolymer 1: From basic research to clinical application. Cell Mol Life Sci CMLS 53(1):24\u201328. https:\/\/doi.org\/10.1007\/PL00000576","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"10","key":"1837_CR84","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1093\/brain\/awq247","volume":"133","author":"M Traka","year":"2010","unstructured":"Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B (2010) A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 133(10):3017\u20133029. https:\/\/doi.org\/10.1093\/brain\/awq247","journal-title":"Brain"},{"issue":"1","key":"1837_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nn.4193","volume":"19","author":"M Traka","year":"2016","unstructured":"Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B (2016) Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci 19(1):65\u201374. https:\/\/doi.org\/10.1038\/nn.4193","journal-title":"Nat Neurosci"},{"issue":"5","key":"1837_CR86","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/187152712801661284","volume":"11","author":"J Van Der Star","year":"2012","unstructured":"Van Der Star J, YS Vogel BM Kipp D, Puentes F, Baker D, Amor S (2012) In Vitro and In Vivo Models of Multiple Sclerosis. CNS Neurol Disorders - Drug Targets 11(5):570\u2013588. https:\/\/doi.org\/10.2174\/187152712801661284","journal-title":"CNS Neurol Disorders - Drug Targets"},{"issue":"7","key":"1837_CR87","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1172\/JCI19388","volume":"113","author":"H Waldner","year":"2004","unstructured":"Waldner H, Collins M, Kuchroo VK (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113(7):990\u2013997. https:\/\/doi.org\/10.1172\/JCI19388","journal-title":"J Clin Invest"},{"key":"1837_CR88","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/ana.410360714","volume":"36","author":"H Wekerle","year":"1994","unstructured":"Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C (1994) Animal models. Ann Neurol 36:S47\u2013S53. https:\/\/doi.org\/10.1002\/ana.410360714","journal-title":"Ann Neurol"},{"key":"1837_CR89","doi-asserted-by":"publisher","first-page":"1458046","DOI":"10.3389\/fphar.2024.1458046","volume":"15","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Xie Z, He L, Sun G, Meng H, Luo Z, Feng Y, Chu X, Li L, Zhang J, Hao Y, Geng M, Zhang X, Chen S (2024) Multi-omics profiling reveals peripheral blood biomarkers of multiple sclerosis: Implications for diagnosis and stratification. Front Pharmacol 15:1458046. https:\/\/doi.org\/10.3389\/fphar.2024.1458046","journal-title":"Front Pharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01837-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:58:41Z","timestamp":1774688321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1837"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01837-5","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}